Posted on by admin

The State of Precision Medicine

REGISTER NOW

Panelists:

Image of Becky Quick

Becky Quick

Anchor
CNBC’s Squawk Box

Panelist

Image of Becky Quick

Becky Quick

Becky Quick is an anchor of CNBC’s popular morning show, Squawk Box, and an award-winning journalist and broadcaster. More importantly, she is the mother of a child with the rare genetic disease, SYNGAP1. The disease, which affects about 1,700 people globally, is derived from a mutation in the SynGAP protein, which is required for brain development. Becky’s daughter Kaylie was diagnosed at three years old, which opened doors to form connections with other families in the rare disease space who are facing similar situations. Becky was the driving force behind the formation of CNBC Cures, hosting and moderating the inaugural summit in New York City in March 2026. The summit featured numerous experts and commentators in rare disease therapeutics and personalized medicine sharing ideas to expedite funding and research for rare genetic disorders.

Becky holds a degree in political science from Rutgers University. Prior to her role as a CNBC anchor, she was a columnist at Fortune and a reporter at the Wall Street Journal.
Image of Anne Wojcicki

Anne Wojcicki

CEO
23andMe Research Institute

Panelist

Image of Anne Wojcicki

Anne Wojcicki

Anne Wojcicki is the founder and CEO of 23andMe and the TTAM Research Institute. She is committed to putting individuals at the center of their health information and decisions with choice and transparency, and in turn empowering them to participate in research. Anne co-founded 23andMe in 2006, three years after the first human genome was sequenced. Her goal was to help people access, understand, and benefit from the human genome and fundamentally change healthcare in the process. Although the company filed for bankruptcy in 2025, Anne maintained her interest in steering the company forward. She formed the TTAM Research Institute, a nonprofit medical research organization, to acquire the company for $305 million.

Prior to founding 23andMe, Anne spent a decade on Wall Street investing in healthcare and felt frustrated by a system built around monetizing illness instead of incentivizing prevention. Anne’s vision and persistence powered an industry-first community approach to genetic research. This novel, web-based research model has resulted in thousands of new genetic discoveries and brought personalized medicine to millions of people.
Image of Brian Bigger, PhD

Brian Bigger, PhD

Chair, Advanced Therapeutics
University of Edinburgh, U.K.

Panelist

Image of Brian Bigger, PhD

Brian Bigger, PhD

Brian Bigger, PhD, is the chair of advanced therapeutics at the Institute of Regeneration and Repair at the University of Edinburgh. His group develops innovative gene and cell therapies, especially neurological lysosomal diseases like Hunter syndrome, and brings these treatments to patients. In particular, the focus is on making novel stem cell gene therapies available to patients with neurological diseases and dementias. Brian’s lab has developed three hematopoietic stem cell gene therapies for mucopolysaccharidosis types II and III (MPS II and MPS III). The first therapy developed in the lab (substrate reduction therapy for MPSIII) entered a Phase III clinical trial in mid 2014.

Brian earned his PhD in gene therapy from Imperial College London. After four years developing a stem cell gene therapy approach for hemophilia B at Cancer Research UK, Brian worked on hematopoietic stem cell migration at the National Blood Service and Oxford University.
Image of Carrie Haverty

Carrie Haverty

Vice President of Medical Affairs & Clinical Strategy
Mirvie

Panelist

Image of Carrie Haverty

Carrie Haverty

Carrie Haverty is vice president of medical affairs and clinical strategy at Mirvie, leading efforts to develop the Mirvie RNA platform using a simple blood test to reveal a pregnancy’s unique biology and predict complications months before they occur. Carrie is also the 2026 president of the National Society of Genetic Counselors, having previously served on the board of directors as chair of the membership committee and various other volunteer roles since she was in graduate school.

Carrie earned her graduate degree in genetic counseling from the University of California, Irvine, and she is a Certified Genetic Counselor. She started her career working in high-risk prenatal care and focused on providing broad access to new diagnostic technologies. Her clinical experience served as the foundation for leading cutting-edge product development and commercialization of new technologies at Counsyl, Myriad Genetics, and Miroculus, prior to joining Mirvie.

Broadcast Date: 
  • Time: 

Welcome to the 2026 State of Precision Medicine virtual summit, hosted by Inside Precision Medicine. This year’s summit focuses on the existing gaps in precision medicine as we ask: How do we make treatment equitable and accessible for all patients across the disease continuum?

On June 3rd, the editors of Inside Precision Medicine will feature an outstanding line-up of guests highlighting the challenges and urgency of expanding access to disease therapies and empowering patients and consumers.

Agenda Highlights:

  • Becky Quick, co-anchor of CNBC’s Squawk Box and the founder of CNBC Cures, discusses her own family’s rare disease journey and her prescription to expand access to rare disease therapeutics 

  • Anne Wojcicki, CEO of the 23andMe Research Institute, speaks on the consumer genetics pioneer’s recent renaissance leading the newly re-imagined organization

  • Brian Bigger, PhD, and Rob Wynn, MD, scientists and clinicians at Manchester University, share insights from their work on stem cell gene therapy and its potential to offer hope for patients with rare diseases such as Hunter syndrome. They are joined by Ricky Chu, father of two children with Hunter syndrome, a rare neurodevelopmental disorder 

  • Carrie Haverty, president of the National Society of Genetic Counselors, hosts a panel on the current trends and challenges in genetic counseling 

  • Saralyn Mark, MD, first senior medical advisor to both the Office on Women’s Health within the HHS and NASA, boldly explores lessons in women’s health with her guests Dorit Donoviel, PhD, and Kim Templeton, MD

  • Breakout sessions from the summit sponsors, including 10x Genomics and Illumina 

Registration is entirely free. We look forward to seeing you on June 3.

Produced with support from:

10x Genomics logo

illumina logo